November 4, 2022Combined low-pass whole genome and targeted sequencing identifies causative mutations and associated genomic scarring indicative of homologous recombination deficiency Read more »
November 4, 2022Validation of genomic profiling by PGDx Plasma Focus to facilitate precision oncology through cell-free DNA testing of solid tumors Read more »
November 4, 2022Pan solid tumor identification of NTRK fusions utilizing RNA sequencing identifies diverse fusion partners Read more »
November 4, 2022Pan solid tumor identification of NRG1 fusions utilizing RNA sequencing identifies diverse fusion partners and highlights a lack of co-occurring oncogenic driver alterations Read more »
